Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

January 30, 2015 7:32 PM

14 0

WASHINGTON (Reuters) - India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the U.S. Federal Trade Commission said on Friday.

Sun Pharmaceutical said in April that it had agreed to buy the Indian generic drugmaker from its current owner, Japan's Daiichi Sankyo Co, for $3.2 billion.

Read more

To category page